QTTB Earnings & Financial Statements
Q32 Bio Inc.
$7.77
-$0.24(-3.00%)
44
Overall
80
Value
18
Tech
36
Quality
Market Cap
$238.45M
Volume
625.33K
52W Range
$1.91 - $23.57
Target Price
$39.60
QTTB earnings and financial statements: Q32 Bio Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
QTTB Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $53.74M | - | -$6.65M | $6.65M | $33.97M |
| Operating income | $16.90M | -$66.10M | -$48.26M | -$133.28M | -$95.95M |
| EBITDA | $31.00M | -$46.44M | -$47.76M | -$38.85M | -$88.31M |
| Net income | $29.80M | -$47.73M | -$53.74M | -$42.81M | -$95.76M |
| EPS (diluted) | $2.42 | $-6.58 | $-35.10 | $-1.62 | $-31.14 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $61.78M | $92.33M | $47.06M | $228.47M | $211.72M |
| Total liabilities | $19.76M | $86.66M | $118.53M | $50.49M | $42.07M |
| Shareholders’ equity | $42.01M | $5.67M | -$182.92M | $177.98M | $169.65M |
| Cash and equivalents | $48.30M | $77.97M | $25.62M | $33.99M | $108.38M |
| Long-term debt | $8.42M | $15.19M | $49.42M | $27.92M | $23.69M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$33.54M | -$67.72M | -$18.68M | -$10.96M | -$32.98M |
| Capital expenditure | $7.00M | -$75.0K | -$5.0K | -$2.48M | -$157.0K |
| Free cash flow | -$33.54M | -$67.79M | -$18.68M | -$13.44M | -$33.14M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | QTTB | $7.77 | -3.0% | 625.33K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |